- M.D., Duke University School of Medicine, Durham, NC
- B.S., Biology, summa cum laude with Honors, Syracuse University, Syracuse, NY
- Residency/Chief Resident, Anatomic and Clinical Pathology, Duke University Medical Center, Durham, NC
- Fellowship, Pulmonary Pathology, Duke University Medical Center
Department of Pathology & Laboratory Medicine
Areas of expertise
Lung cancer staging, occupational lung disease, mesothelioma, pulmonary fibrosis.
BIO
Kelly J. Butnor, MD, is a Professor of Pathology & Laboratory Medicine in the Clinical Scholar Pathway at the Larner College of Medicine at the University of Vermont. She is the Section Head of Thoracic Pathology and is board-certified in Anatomic and Clinical Pathology. Her clinical andr research interests include neoplastic and non-neoplastic lung pathology, including occupational lung disease and mesothelioma. Dr. Butnor is actively engaged in educating learners at a variety of levels, including post-graduate colleagues, fellows, residents, and medical students. Internationally recognized for her work in the staging of lung cancer, occupational lung disease, and mesothelioma, Dr. Butnor has chaired the Lung Cancer Panel for the International Collaboration on Cancer Reporting (ICCR) and the Thoracic Cancer Protocol Review Committee for the College of American Pathologists (CAP) Cancer Committee. She serves on the United States-Canadian Mesothelioma Reference Panel, the Pulmonary Pathology Society (PPS) Program Committee, the International Mesothelioma Panel, and was also a member of the American Joint Committee on Cancer (AJCC) 8th Edition Thoracic Expert Panel. Her publications focus on the pathologic staging of lung cancer, the diagnosis of mesothelioma, and pulmonary fibrosis. A dedicated educator, she has received the departmental Pathology Attending Teaching Award and been invited to serve as Visiting Professor at several institutions. Dr. Butnor is committed to providing the highest quality care to patients in Vermont and the surrounding region.
Courses
- Cardiovascular, Respiratory, and Renal Systems (CRR) (MD 559)
Publications
Awards and Achievements
- Pathology Attending Teaching Award, University of Vermont Medical Center 2022
- Visiting Professor, Mayo Clinic Arizona Department of Laboratory Medicine and Pathology, Scottsdale, AZ 2022
- Visiting Professor, Mayo Clinic Department of Laboratory Medicine and Pathology, Rochester, MN 2025
Bio
Kelly J. Butnor, MD, is a Professor of Pathology & Laboratory Medicine in the Clinical Scholar Pathway at the Larner College of Medicine at the University of Vermont. She is the Section Head of Thoracic Pathology and is board-certified in Anatomic and Clinical Pathology. Her clinical andr research interests include neoplastic and non-neoplastic lung pathology, including occupational lung disease and mesothelioma. Dr. Butnor is actively engaged in educating learners at a variety of levels, including post-graduate colleagues, fellows, residents, and medical students. Internationally recognized for her work in the staging of lung cancer, occupational lung disease, and mesothelioma, Dr. Butnor has chaired the Lung Cancer Panel for the International Collaboration on Cancer Reporting (ICCR) and the Thoracic Cancer Protocol Review Committee for the College of American Pathologists (CAP) Cancer Committee. She serves on the United States-Canadian Mesothelioma Reference Panel, the Pulmonary Pathology Society (PPS) Program Committee, the International Mesothelioma Panel, and was also a member of the American Joint Committee on Cancer (AJCC) 8th Edition Thoracic Expert Panel. Her publications focus on the pathologic staging of lung cancer, the diagnosis of mesothelioma, and pulmonary fibrosis. A dedicated educator, she has received the departmental Pathology Attending Teaching Award and been invited to serve as Visiting Professor at several institutions. Dr. Butnor is committed to providing the highest quality care to patients in Vermont and the surrounding region.
Courses
- Cardiovascular, Respiratory, and Renal Systems (CRR) (MD 559)
Publications
Awards and Achievements
- Pathology Attending Teaching Award, University of Vermont Medical Center 2022
- Visiting Professor, Mayo Clinic Arizona Department of Laboratory Medicine and Pathology, Scottsdale, AZ 2022
- Visiting Professor, Mayo Clinic Department of Laboratory Medicine and Pathology, Rochester, MN 2025
Select Publications
- Cooper WA, Webster F, Butnor KJ, Calabrese F, Chou TY, Hwang DM, Kern I, Popat S, Sholl L, Yatabe Y, Nicholson AG. Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 2025;86:665-680
- Husain A, Chapel DB, Attanoos R, Beasley MB, Brcic L, Butnor K, Chirieac LR, Churg A, Dacic S, Galateau-Salle F, Hiroshima K, Hung YP, Klebe S, Krausz T, Khoor A, Litzky L, Marchevsky A, Nabeshima K, Nicholson AG, Pavlisko EN, Roden AC, Roggli V, Sauter JL, Schulte JJ, Sheaff M, Travis WD, Tsao MS, Walts AE, Colby TV. Guidelines for pathologic diagnosis of mesothelioma: 2023 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med 2024;148:1251-1271
- Rosen LE, Ananthanarayanan A, Gallan A, Tjota MY, Attanoos R, Alchami FS, Brcic L, Butnor KJ, Hiroshima K, Klampatsa A, Litzky L, Marchevsky AM, Medeiros F, Montero-Fernandez MA, Moore DA, Nabeshima K, Pavlisko EN, Sharma A, Sheaff M, Walts AE, Galateau F, Stang NL, Krausz T, Husain AN. Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study. Mod Pathol 2018;31(4):598–606
- Cunniff B, Newick K, Nelson KJ, Wozniak AN, Beuschel S, Leavitt B, Bhave A, Butnor K, Koenig A, Chouchani ET, James AM, Haynes AC, Lowthere WT, Murphy MP, Shukla A, Heintz NH. Disabling mitochondrial peroxide metabolism via combinatorial targeting of peroxiredoxin 3 as an effective therapeutic approach for malignant mesothelioma. PLoS ONE 2015;10(5):e0127310 5) Butnor KJ, Guinee DG. Pleuropulmonary pathology of Birt-Hogg-Dube syndrome. Am J Surg Pathol 2006;30(3):395–399